Antibodies against PCSK9—a new era of therapy

被引：8
|
作者：
Alexandra King
机构：
来源：
Nature Reviews Cardiology | 2013年 / 10卷 / 1期
关键词：
D O I：
10.1038/nrcardio.2012.166
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 1
相关论文
共 50 条
  • [21] ESC 2024 - Acute Coronary Syndrome (ACS) PCSK9 Antibodies in acute Coronary Syndrome: the early Therapy Era
    Bressnig, Mag Birgit
    JOURNAL FUR KARDIOLOGIE, 2024, 31 (11-12):
  • [22] A Therapeutic Peptide Vaccine Against PCSK9
    Yajie Pan
    Yanzhao Zhou
    Hailang Wu
    Xiao Chen
    Xiajun Hu
    Hongrong Zhang
    Zihua Zhou
    Zhihua Qiu
    Yuhua Liao
    Scientific Reports, 7
  • [23] PCSK9: a new target for hypercholesterolemia
    Cariou, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 16 - 16
  • [24] Promising results with siRNA against PCSK9
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2017, 14 (5) : 252 - 252
  • [25] A Therapeutic Peptide Vaccine Against PCSK9
    Pan, Yajie
    Zhou, Yanzhao
    Wu, Hailang
    Chen, Xiao
    Hu, Xiajun
    Zhang, Hongrong
    Zhou, Zihua
    Qiu, Zhihua
    Liao, Yuhua
    SCIENTIFIC REPORTS, 2017, 7
  • [26] PCSK9 is a new target of FXR
    Langhi, C.
    Arnaud, L.
    Jarnoux, Al
    Krempf, M.
    Costet, P.
    Cariou, B.
    DIABETES & METABOLISM, 2007, 33 : S39 - S39
  • [27] PCSK9
    Abifadel, M.
    Boileau, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [28] New prospects for PCSK9 inhibition?
    Landmesser, Ulf
    Chapman, M. John
    Stock, Jane K.
    Amarenco, Pierre
    Belch, Jill J. F.
    Boren, Jan
    Farnier, Michel
    Ference, Brian A.
    Gielen, Stephan
    Graham, Ian
    Grobbee, Diederick E.
    Hovingh, G. Kees
    Luscher, Thomas F.
    Piepoli, Massimo F.
    Ray, Kausik K.
    Stroes, Erik S.
    Wiklund, Olov
    Windecker, Stephan
    Luis Zamorano, Jose
    Pinto, Fausto
    Tokgozoglu, Lale
    Bax, Jeroen J.
    Catapano, Alberico L.
    EUROPEAN HEART JOURNAL, 2018, 39 (27) : 2600 - 2601
  • [29] A New Approach to PCSK9 Therapeutics
    Wang, Nan
    Tall, Alan R.
    CIRCULATION RESEARCH, 2017, 120 (07) : 1063 - 1065
  • [30] PCSK9 and a new target of FXR
    Langhi, C.
    Arnaud, L.
    Jarnoux, A. L.
    Krempf, M.
    Costet, P.
    Cariou, B.
    DIABETES & METABOLISM, 2007, 33 : S31 - S31
12345